Novo Nordisk Inc.: Drug Recall

Recall Details

Recall Number

D-0245-2026

Classification

Class II

Product Type

Drug

Recalling Firm

Novo Nordisk Inc.

Status

Ongoing

Date Initiated

12/19/2025

Location

Plainsboro, NJ, United States

Voluntary/Mandated

Voluntary: Firm initiated

Product Quantity

N/A

Reason for Recall

Presence of Particulate Matter: Hair was found in a prefilled syringe

Product Description

Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14

Distribution Pattern

Nationwide within the United States.

Other Recalls by Novo Nordisk Inc.

• Class II: Risk 12/19/2025
  Presence of Particulate Matter: Hair was found in a prefilled syringe
• Class II: Risk 03/22/2021
  Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
• Class I: Dangerous 03/22/2021
  Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
• Class II: Risk 03/22/2021
  Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
• Class II: Risk 03/22/2021
  Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

View all recalls by Novo Nordisk Inc. →